The Update of Active Surveillance Around the World: Utilization and Outcomes
Enrollment criteria PSAD <0.15, clinical stage T1c, Gleason score ≤6, ≤2 positive cores, and ≤50% involvement of any core (preferred); or PSA <10, clinical stage ≤T2a, and Gleason score ≤6 Monitoring PSA + DRE every…